Prot # SD-809-C-20: An Open-Label, Long-Term Safety Study of SD-809(Deutetrabenazine) for the Treatment of Moderate to Severe Tradive Dyskinesia

Project: Research project

Project Details

StatusFinished
Effective start/end date1/9/15 → 1/9/18

Funding

  • INNO Clinical Outcomes, LLC (SD-809-C-20 // SD-809-C-20)
  • Auspex Pharmaceuticals, Inc. (SD-809-C-20 // SD-809-C-20)